PeckhamMJ, BarrettA, LiewKH, HorwichA, RobinsonB, DobbsHJ, et al. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer, 1983; 47(5):613–619.
2.
BauerK, SkoetzN, MonsefI, EngertA, BrillantC. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Database Syst Rev, 2011;(8):CD007941.
3.
KinjoT, TomaruK, HainesDC, KlinmanDM. The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy. Respir Res, 2012; 13:47.
4.
WhiteDA, StoverDE. Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids. Chest, 1984; 86(5):723–728.
5.
GarridoM, O'BrienA, GonzalezS, ClaveroJM, OrellanaE. Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report. Chest, 2007; 132(6):1997–1999.
QuigleyM, BradaM, HeronC, HorwichA. Severe lung toxicity with a weekly low dose chemotherapy regimen in patients with non-Hodgkin's lymphoma. Hematol Oncol, 1988; 6(4):319–324.
FildermanAE, GenoveseLA, LazoJS. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice. Biochem Pharmacol, 1988; 37(6):1111–1116.
10.
TrykaAF, SkornikWA, GodleskiJJ, BrainJD. Potentiation of bleomycin-induced lung injury by exposure to 70% oxygen. Morphologic assessment. Am Rev Respir Dis, 1982; 126(6):1074–1079.
11.
TrykaAF, GodleskiJJ, BrainJD. Differences in effects of immediate and delayed hyperoxia exposure on bleomycin-induced pulmonary injury. Cancer Treat Rep, 1984; 68(5):759–764.
12.
HaasCD, ColtmanCAJr, GottliebJA, HautA, LuceJK, TalleyRW, et al. Phase II evaluation of bleomycin. A Southwest Oncology Group study. Cancer, 1976; 38(1):8–12.
JensenJL, GoelR, VennerPM. The effect of corticosteroid administration on bleomycin lung toxicity. Cancer, 1990; 65(6):1291–1297.
16.
NgAK, LiS, NeubergD, ChiR, FisherDC, SilverB, et al. A prospective study of pulmonary function in Hodgkin's lymphoma patients. Ann Oncol, 2008; 19(10):1754–1758.
17.
ShoferS, BadeaC, QiY, PottsE, FosterWM, JohnsonGA. A micro-CT analysis of murine lung recruitment in bleomycin-induced lung injury. J Appl Physiol, 2008; 105(2):669–677.
BeasleyMB, FranksTJ, GalvinJR, GochuicoB, TravisWD. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med, 2002; 126(9):1064–1070.
20.
CortA, OzdemirE, TimurM, OzbenT. Effects of N-acetyl-l-cysteine on bleomycin induced oxidative stress in malignant testicular germ cell tumors. Biochimie, 2012; 94(12):2734–2739.
21.
LiS, YangX, LiW, LiJ, SuX, ChenL, et al. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats. Respiration, 2012; 84(6):509–517.
22.
GilsonAJ, SahnSA. Reactivation of bleomycin lung toxicity following oxygen administration. A second response to corticosteroids. Chest, 1985; 88(2):304–306.
23.
SetoT, SekiN, UematsuK, TanigakiT, ShioyaS, KoboyashiT, et al. Gefitinib-induced lung injury successfully treated with high-dose corticosteroids. Respirology, 2006; 11(1):113–116.
24.
YamamotoK, KatoT, ShindoJ, AndoM, AbeT, ShirakiA, et al. [A case of irinotecan or panitumumab-induced interstitial pneumonia successfully treated by steroid pulse therapy]. Gan To Kagaku Ryoho, 2012; 39(2):305–309. Article in Japanese.
25.
LaiYC, LinPC, LaiJI, HsuSY, KuoLC, ChangSC, et al. Successful treatment of erlotinib-induced acute hepatitis and acute interstitial pneumonitis with high-dose corticosteroid: a case report and literature review. Int J Clin Pharmacol Ther, 2011; 49(7):461–466.
26.
MaherJ, DalyPA. Severe bleomycin lung toxicity: reversal with high dose corticosteroids. Thorax, 1993; 48(1):92–94.
BloorAJ, SealeJR, MarcusRE. Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma. Clin Lab Haematol, 1998; 20(2):119–121.
